1. Key multiplicity issues in clinical drug development;Dmitrienko;Stat. Med.,2013
2. Multiple endpoints in clinical trials, Guid;US Food and Drug Administration;Ind,2017
3. Committee for Proprietary Medicinal Products. Points to Consider on Multiplicity Issues in Clinical Trials;European Medicines Agency,2002
4. Multiple comparison procedures;Hochberg,1987
5. Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment;Westfall,1993